Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A

NCT00984126 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00984126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00984126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
October 26, 2009
Completion date
June 29, 2016
Enrollment
214 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a